About

Asad Ali Ahmad, PhD is an accomplished healthcare innovator and investor with a passion for building seed-stage companies. With over 8 years of relevant experience, he has gained a reputation as a leader in healthcare RWE technology. As an investor, he is focused on phenotypic platforms, decentralized data, and drug repurposing. Currently, Asad is an Investor at REM Capital, where he works with the BioPharma industry to generate $15M annually and manages a team of 25 rockstars. He personally sold and managed ~100 engagements across 20+ partners. Prior to this, he worked as Global Key Accounts at Tempus Labs, Inc., where he helped build the precision medicine thesis in CVD. He was also instrumental in creating the deepest Oncology clinico-genomic dataset at Tempus, which is now the RWD category leader with a half decade of full RNA, 50x DNA capture. Asad's past experience includes working as a mentor at Circklo, a sustainability-focused seed-stage accelerator. He also incubated healthcare and AI/ML ideas. Asad's educational background is impressive, having earned a PhD in Biomedical Engineering from the University of North Carolina in 2015. Asad is a lover of many things, including his baby girl, hooping, vinyls, trying to break 80, and keeping his resting heart rate below 50. He is proficient in NLP, AI, Big Data, and ML.